State-of-the-art in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors: Evolutionary trends in diagnosis, monitoring and treatment

TY - JOUR

T1 - State-of-the-art in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors

T2 - Evolutionary trends in diagnosis, monitoring and treatment

AU - Aguayo, Alvaro

AU - Couban, Stephen

PY - 2009

Y1 - 2009

KW - Chronic myelogenous leukemia

KW - Imatinib

KW - Therapy

KW - Tyrosine kinase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=73849126019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73849126019&partnerID=8YFLogxK

U2 - 10.3109/10428190903370387

DO - 10.3109/10428190903370387

M3 - Review article

C2 - 20017605

AN - SCOPUS:73849126019

SN - 1042-8194

VL - 50

SP - 1

EP - 8

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - SUPPL. 2

ER -